New data support renal and cardiovascular benefits of Kerendia™ (finerenone) in patients with and without history of left ventricular hypertrophy and chronic kidney disease and type 2 diabetes
Berlin, May 23, 2022 - Late-breaking data from an exploratory post hoc analysis from FIDELITY, a prespecified pooled analysis of ...
Read more